Skip to main content

Analytical White Papers

Free analytical and research White Papers on the topic of reimbursement, HTA and evidence requirements for medical devices and IVD tests in Europe

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

The application period for changes to the 2025/26 High Cost Device List open

Some High Cost devices are excluded from the calculation of HRG prices under the NHS Payment Scheme. These items are paid in addition to the price of the related service. To nominate a device for inclusion in (or removal from) the High Cost Device List, the form should be completed and submitted to by the end of May before the subsequent year’s NHS Payment Scheme. 

Thus, for applications to be considered for 2025/26, the completed form needs to be submitted by May 31, 2024.

See the full details here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.